Page last updated: 2024-10-25

citalopram and Ophthalmoplegia, Progressive Supranuclear

citalopram has been researched along with Ophthalmoplegia, Progressive Supranuclear in 1 studies

Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chinaglia, G1
Landwehrmeyer, B1
Probst, A1
Palacios, JM1

Other Studies

1 other study available for citalopram and Ophthalmoplegia, Progressive Supranuclear

ArticleYear
Serotoninergic terminal transporters are differentially affected in Parkinson's disease and progressive supranuclear palsy: an autoradiographic study with [3H]citalopram.
    Neuroscience, 1993, Volume: 54, Issue:3

    Topics: Aged; Aged, 80 and over; Autoradiography; Basal Ganglia; Biomarkers; Carrier Proteins; Caudate Nucle

1993